EUVIMEDEUVIMED entdecken
Crossref

Maintained disease control and steroid-sparing effect of subcutaneous immunotherapy in allergic rhinitis and asthma

Asian Pacific Journal of Allergy and Immunology · 2023

DOI: 10.12932/-0309ap21-1222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Pacific Journal of Allergy and Immunology, 2023.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergen immunotherapy is the only currently available treatment strategy that modifies the immune response to the causative allergen and induces clinical improvement and a steroid-sparing effect.

Objective

In this real-life study, we aimed to evaluate and compare the efficacy of subcutaneous immunotherapy (SCIT) with one allergen or multiple allergens in children and adults with asthma and/or allergic rhinitis in terms of disease control and a steroid-sparing effect.

Methods

Demographics, the initial inhaled corticosteroid (ICS) and/or intranasal corticosteroid (INS) dose, and other drugs of patients receiving SCIT for at least 12 months were recorded.Data on the final dose/use of ICS/INS and asthma and/or allergic rhinitis control were gathered.

Results

Of 104 patients included, 57.1% and 64.5% of patients with asthma and allergic rhinitis, respectively, were able to discontinue ICS and INS after SCIT.The median time to INS and ICS dose reduction was 6 months.SCIT with one allergen or multiple allergens effectively reduced the ICS and INS dose and led to control of asthma and allergic rhinitis, with no significant difference between the groups.When the efficacy of SCIT was compared in children and adults, there was no significant difference in terms of a steroid-sparing effect or the control of asthma and allergic rhinitis.SCIT was effective in both children and adult patients. Conclusion:In this real-life observational study, we have demonstrated a marked steroid-sparing effect while maintaining control of asthma and allergic rhinitis in children and adults treated with one allergen or multiple allergens.

Zitieren

APA

(2023). Maintained disease control and steroid-sparing effect of subcutaneous immunotherapy in allergic rhinitis and asthma. Asian Pacific Journal of Allergy and Immunology. https://doi.org/10.12932/-0309ap21-1222

Vancouver

Maintained disease control and steroid-sparing effect of subcutaneous immunotherapy in allergic rhinitis and asthma. Asian Pacific Journal of Allergy and Immunology. 2023. doi:10.12932/-0309ap21-1222

BibTeX
@article{euvimed2023,
  title = {Maintained disease control and steroid-sparing effect of subcutaneous immunotherapy in allergic rhinitis and asthma},
  journal = {Asian Pacific Journal of Allergy and Immunology},
  year = {2023},
  doi = {10.12932/-0309ap21-1222}
}
Kostenlos starten →